Share price: 104.00p

Result of General Meeting

18th February 2017

Cello Group plc (AIM: CLL; “Cello”, the “Group” or the “Company”), the healthcare focused strategic marketing group, is pleased to announce that at its General Meeting held earlier today, all resolutions in connection with the conditional placing of 10,309,279 new ordinary shares of 10 pence each in the Company (“Ordinary Shares”), as announced by the Company on 1 February 2017, were duly passed. Admission of the new Ordinary Shares is expected on 20 February 2017.

17 February 2017

This announcement contains inside information.

Enquiries:

Cello Group
020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Group Finance Director
Cenkos Securities
0207 397 8900
Bobbie Hilliam / Harry Pardoe – NOMAD
Julian Morse / Michael Johnson – Sales
Buchanan
020 7466 5000
Richard Oldworth
Jamie Hooper
Madeleine Seacombe

 

Contact Us

Dianna Hillier

Dianna.Hillier@cellohealth.com

Phone 020 7812 8468

Address

Cello Health plc

Queens House

8-9 Queen Street

London

EC4N 1SP

Registered Office

Queens House

8-9 Queen Street

London

EC4N 1SP

Company Registered

in England no.05120150